XML 11 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 61,065 $ 157,168
Accounts receivable, net 194,978 196,089
Inventory 29,192 41,779
Prepaid expenses and other current assets 40,579 25,791
Total current assets 325,814 420,827
Non-current assets:    
Capitalized software development costs, net 18,616
Intangible assets, net 1,342,081 1,360,109
Total assets 1,667,895 1,799,552
Current Liabilities:    
Accounts payable 318,768 340,962
Other current liabilities 339,645 343,945
Loans payable 391,700 438,254
Convertible notes payable 1,209,147 1,284,147
Total current liabilities 2,259,260 2,407,308
Total liabilities 2,259,260 2,407,308
Commitments and contingencies (Note 14)
Stockholders’ Deficit:    
Common stock, 900,000,000 shares authorized, $0.0001 par value; 11,281,527 and 10,806,527 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 1,128 1,081
Additional paid-in capital 3,818,094 3,722,141
Accumulated deficit (4,410,959) (4,331,350)
Total stockholders’ deficit (591,365) (607,756)
Total liabilities and stockholders’ deficit 1,667,895 1,799,552
Series A Preferred Stock [Member]    
Stockholders’ Deficit:    
Preferred stock , value 108 108
Series A-2 Preferred Stock [Member]    
Stockholders’ Deficit:    
Preferred stock , value $ 264 $ 264